CIK 0001997296 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Medicus Pharma Ltd.
Sign in to watch- Ticker
- MDCX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ontario, Canada
- Entity type
- operating
- EIN
- 981778211
- Phone
- 610-540-7515
- Business address
- 300 CONSHOHOCKEN STATE RD., SUITE 200, W. CONSHOHOCKEN, PA, 19428
Securities
- MDCX Common Stock Nasdaq
- MDCXW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-22 | Brennan Edward J. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-07-22 | Bonner Carolyn F. President | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-07-22 | Bokhari Raza Chief Executive Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2025-07-22 | Ashton William Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-05-20 | VELOCITY FUND PARTNERS, LP 10% owner | Sale | −75,000 | $7.72 | $579K | 3,248,741 |
Page 4 of 4 · 65 trades